Paper3970930
Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
Nygård O and 1 other. Biochim Biophys Acta, 1985. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes. Papers, record 3970930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3970930
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Diphosphate Ribose | Major topic |
| Nucleoside Diphosphate Sugars | Major topic |
| Peptide Elongation Factors | Major topic |
| Ribosomes | Major topic |
| Animals | |
| Diphtheria Toxin | |
| Guanosine Diphosphate | |
| Guanosine Triphosphate | |
| NAD | |
| Peptide Elongation Factor 2 | |
| Protein Binding | |
| Rabbits | |
| Rats | |
| Structure-Activity Relationship |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37246715 | eEF2 diphthamide modification restrains spurious frameshifting to maintain translational fidelity. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/37246715 | PubMed |
| 33546365 | MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential. | Cells | 2021 | https://conductscience.org/library/papers/33546365 | PubMed |
| 32029452 | PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis. | Genes Dev | 2020 | https://conductscience.org/library/papers/32029452 | PubMed |
| 23861744 | Modes of action of ADP-ribosylated elongation factor 2 in inhibiting the polypeptide elongation cycle: a modeling study. | PLoS One | 2013 | https://conductscience.org/library/papers/23861744 | PubMed |
| 11681712 | Eukaryotic elongation factor 2 can bind to the synthetic oligoribonucleotide that mimics sarcin/ricin domain of rat 28S ribosomal RNA. | Mol Cell Biochem | 2001 | https://conductscience.org/library/papers/11681712 | PubMed |
| 8633041 | Truncated elongation factor G lacking the G domain promotes translocation of the 3' end but not of the anticodon domain of peptidyl-tRNA. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8633041 | PubMed |
| 8070397 | Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus. | EMBO J | 1994 | https://conductscience.org/library/papers/8070397 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3970930
GET https://conductscience.org/api/papers/v1/3970930/authors